PeptaPeptides

Dual GIP/GLP-1 receptor agonist at 60 mg — the highest available research dose. Tirzepatide activates both incretin receptors simultaneously, enabling studies of complementary metabolic pathway engagement beyond single-receptor models.

Dual GIP/GLP-1 receptor agonist at 30 mg. Mid-range research quantity for multi-dose chronic study designs studying incretin dual-agonism, metabolic regulation, and adipose tissue biology.

Dual GIP/GLP-1 receptor agonist at 10 mg — entry-level research quantity for pilot studies, in vitro receptor binding assays, and dose-finding experiments.

Long-acting GLP-1 receptor agonist with a C18 fatty diacid modification enabling albumin binding and extended half-life. The gold-standard GLP-1 research tool for metabolic, appetite, and neuroprotective studies.

Semaglutide at 10 mg — ideal for pilot experiments, in vitro GLP-1 receptor binding studies, and short-duration animal protocols.

Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Retatrutide represents the next generation of incretin-based metabolic research tools beyond dual-agonism.

Triple GLP-1/GIP/glucagon receptor agonist at 20 mg — for moderate-scale preclinical study designs and multi-dose animal experiments.

Triple GLP-1/GIP/glucagon receptor agonist at 10 mg — entry quantity for initial characterization and in vitro pilot studies.

Pre-weighed 5 mg combination of cagrilintide (long-acting amylin analogue) and semaglutide (GLP-1 agonist) for research studying the additive and synergistic effects of complementary metabolic mechanisms in a single protocol.

Long-acting amylin receptor agonist analogue with an extended half-life enabling once-weekly dosing in research models. Studies the role of central amylin receptor activation in satiety, glucose homeostasis, and body weight regulation.

Dual GLP-1/glucagon receptor agonist (IBI362) with balanced activity at both target GPCRs. Studied for its combined effects on insulin secretion, thermogenesis, and hepatic lipid metabolism in metabolic syndrome models.

C-terminal fragment of human growth hormone corresponding to residues 177–191. Studied for its lipolytic properties via adipose tissue β-adrenergic stimulation without the anabolic or IGF-1-stimulating effects of full-length hGH.

Reduced form of the endogenous tripeptide γ-L-glutamyl-L-cysteinyl-glycine. The cell's primary antioxidant defense molecule, studied for its roles in oxidative stress protection, immune function, and xenobiotic detoxification.

Mitochondria-encoded 16-amino acid peptide derived from the 12S rRNA mitochondrial gene. Studied for its role in AMPK activation, insulin sensitization, and mitochondrial biogenesis — a key molecule in the emerging mitochondrial peptidome.

Mitochondria-targeted tetrapeptide that selectively accumulates in the inner mitochondrial membrane via cardiolipin binding. Studied for its roles in mitochondrial cristae preservation, ROS scavenging, and cardioprotection.

Cell-permeable AMPK activator that mimics the effects of AMP. Widely used as a research tool to activate the AMPK/PGC-1α axis, stimulate mitochondrial biogenesis, and enhance glucose uptake in skeletal muscle and metabolic tissue models.

Small-molecule inhibitor of Nicotinamide N-Methyltransferase (NNMT), an enzyme overexpressed in adipose tissue that depletes the methyl donor SAM and reduces NAD+ availability. Studied for metabolic and adipose tissue biology applications.

GHRH analogue featuring a Drug Affinity Complex modification that extends plasma half-life to 6–8 days. Used in pituitary research and GH secretion studies requiring sustained stimulation.

Selective ghrelin receptor agonist with a clean GH-release profile. Unlike GHRP-6, it does not significantly elevate cortisol, prolactin, or appetite — a precise tool for isolating GH-pathway effects.

Synthetic tetrapeptide (Lys-Glu-Asp-Gly) originally isolated from the thymus gland. Studied for immune modulation, thymus restoration, and T-cell function in aging and immunodeficiency research models.

Stabilized analogue of GHRH(1-44) with a trans-3-hexenoic acid modification improving plasma stability. Studied for GH pulse stimulation, visceral adipose tissue reduction mechanisms, and IGF-1 regulation research.

C-terminal fragment of human growth hormone (amino acids 176–191) with selective lipolytic activity. Studied for fat metabolism mechanisms independent of IGF-1 stimulation or GH receptor agonism.

Pre-weighed combination of tesamorelin (GHRH analogue) and ipamorelin (GHS-R1a agonist) targeting the GH axis through complementary mechanisms — GHRH receptor stimulation plus direct pituitary somatotroph activation.

Modified IGF-1 analogue with an N-terminal 13-amino acid extension and Arg³ substitution that dramatically reduce binding to IGF-binding proteins (IGFBPs), extending biological half-life and increasing free bioavailability in research models.

Pentadecapeptide comprising a partial sequence of Body Protection Compound. Extensively studied for gastric mucosal healing, tendon-to-bone repair, and angiogenesis — one of the most replicated healing peptides in the preclinical literature.

Synthetic analogue of the Thr1–Ser43 fragment of endogenous Thymosin Beta-4. Research establishes its role in actin sequestration, cellular migration, and angiogenic signaling.

Pre-weighed combination of BPC-157 (10 mg) and TB-500 (10 mg) for research studies exploring the complementary and additive healing mechanisms of simultaneous angiogenesis/mucosal repair and actin-mediated cellular migration.

C-terminal tripeptide (Lys-Pro-Val) of alpha-melanocyte stimulating hormone with potent anti-inflammatory activity. Studied for gut epithelial protection, mucosal healing, and MC1R/MC3R-independent anti-inflammatory signaling.

Copper-complexed tripeptide (Gly-His-Lys) with established roles in collagen synthesis stimulation, wound healing, and anti-inflammatory signaling. Extensively studied in dermatological and tissue remodeling research.

Naturally occurring 28-amino acid peptide derived from the thymus gland. Studied for immune system modulation, T-cell maturation, and innate immune response enhancement in infection and oncology research models.

The only human cathelicidin — a 37-amino acid cationic amphipathic helical peptide with direct antimicrobial activity, immunomodulatory signaling, and wound healing properties. Studied across infection biology, innate immunity, and skin repair research.

Synthetic peptide corresponding to the HDM-2-binding domain of p53 (residues 12–26) fused to a membrane-penetrating sequence. Studied for selective cancer cell membrane disruption and p53 pathway research in oncology models.

Octapeptide analogue of the N-terminal fragment of SNAP-25, a protein involved in neuromuscular junction vesicle fusion. Studied as a research tool for investigating SNARE complex modulation and acetylcholine release in synaptic transmission models.

Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal peptide extract epithalamin. Studied for telomerase activation, antioxidant activity, and circadian rhythm regulation in aging research models.

Heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin. Research focuses on modulation of BDNF expression, GABAergic activity, and IL-6 regulation in anxiety and cognitive function models.

Synthetic tripeptide (Glu-Asp-Arg) with documented neuroprotective and pineal gland regulatory activities. Studied for effects on melatonin synthesis regulation, retinal protection, and age-related CNS decline in preclinical models.

Neuropeptide originally isolated from rabbit cerebral venous blood. Studied for its effects on sleep architecture, stress hormone modulation, and neuroendocrine regulation.

Proprietary research-grade blend targeting multiple inflammatory and healing pathways simultaneously. Formulated for researchers studying the combined anti-inflammatory, antimicrobial, and tissue repair effects of complementary peptide mechanisms.

Cyclic heptapeptide MC4R agonist structurally derived from alpha-MSH. Studied for CNS-mediated mechanisms via hypothalamic melanocortin-4 receptor pathways — a mechanism clearly distinct from peripheral PDE5 inhibition.

Cyclic heptapeptide analogue of α-MSH with broad melanocortin receptor activity. Extensively studied for pigmentation signaling, MC1R/MC4R activation, and central pathway research.

Essential coenzyme involved in redox reactions across all living cells. Studied for its roles in mitochondrial biogenesis, DNA repair, sirtuin activation, and metabolic regulation in aging and metabolic disease research.

Bulk research pack: 5 × 120 mg tirzepatide vials (600 mg total). Ideal for large-scale chronic studies, multi-arm experiments, or research programs requiring extended GLP-1/GIP dual-agonist supply.

Bulk pack: 5 × 60 mg tirzepatide (300 mg total) at discounted bulk pricing. For mid-scale chronic studies and multi-cohort experimental designs.

Bulk pack: 10 × 30 mg tirzepatide (300 mg total) — ideal for studies requiring multiple independently verified vials to minimize between-vial variability.

Bulk pack: 10 × 10 mg tirzepatide (100 mg total). Designed for in vitro assay programs requiring multiple independently prepared vials or parallel arm studies.

Bulk pack: 5 × 20 mg semaglutide (100 mg total). For extended GLP-1 receptor research programs with high weekly dosing requirements.

Bulk pack: 10 × 10 mg semaglutide (100 mg total). Ideal for multi-arm GLP-1 studies or programs requiring traceability across many independently verified doses.

Bulk pack: 5 × 40 mg retatrutide (200 mg total). For comprehensive triple-agonist research programs studying GLP-1/GIP/glucagon receptor co-activation.

Bulk pack: 10 × 10 mg retatrutide (100 mg total). For high-throughput in vitro triple-receptor assay programs.

Bulk pack: 10 × 10 mg cagrilintide (100 mg total). For chronic amylin receptor agonism studies requiring extended protocol supply.

Bulk pack: 10 × 10 mg BPC-157 (100 mg total). For long-duration healing studies, multi-cohort experiments, or programs studying BPC-157's multi-modal healing mechanisms at scale.

Bulk pack: 10 × 10 mg MOTS-C (100 mg total). For extended mitochondrial peptide research programs studying AMPK pathway modulation and metabolic senescence.

Everything you need to start reconstituting and storing research peptides. Includes 2× Bacteriostatic Water (30 mL each) and a professional 12-vial organizer. Bundle & Save 28%.

• 2× Bacteriostatic Water 30 mL (USP Grade)
• 1× Professional 12-Vial Organizer

The complete starter kit: Bacteriostatic Water, vial organizer, and one of the most studied healing peptides in research — BPC-157 10 mg. Bundle & Save 22%.

• 2× Bacteriostatic Water 30 mL (USP Grade)
• 1× Professional 12-Vial Organizer
• 1× BPC-157 10 mg (≥99.2% purity)

The gold-standard healing peptide research kit. Bac Water ×4, professional vial organizer, BPC-157 10 mg, and TB-500 10 mg. Two of the most studied healing compounds together. Bundle & Save 25%.

• 4× Bacteriostatic Water 30 mL (USP Grade)
• 1× Professional 12-Vial Organizer
• 1× BPC-157 10 mg (≥99.2% purity)
• 1× TB-500 10 mg (≥99.5% purity)